These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 929135

  • 1. [Combined form of chronic aggressive hepatitis primary biliary cirrhosis].
    Zimmermann K, Cueni B, Schmid M.
    Schweiz Med Wochenschr; 1977 Dec 03; 107(48):1749-52. PubMed ID: 929135
    [Abstract] [Full Text] [Related]

  • 2. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y, Tanaka N, Osuga T, Aikawa T, Shoda J, Doi M, Nakano M.
    Am J Gastroenterol; 1990 Jan 03; 85(1):15-23. PubMed ID: 1967512
    [Abstract] [Full Text] [Related]

  • 3. Clinical correlations and significance of orceinpositivity in chronic active hepatitis and primary biliary cirrhosis.
    Salaspuro MP, Sipponen P, Ikkala E, Kolho L, Makkonen HM, Miettinen TA, Räsänen JA, Siurala M.
    Ann Clin Res; 1976 Jun 03; 8(3):206-15. PubMed ID: 63265
    [Abstract] [Full Text] [Related]

  • 4. Immunological parameters, viral antibodies, and biochemical and histological findings in relatives of patients with chronic active hepatitis and primary biliary cirrhosis.
    Salaspuro MP, Laitinen OI, Lehtola J, Makkonen H, Räsänen JA, Sipponen P.
    Scand J Gastroenterol; 1976 Jun 03; 11(3):313-20. PubMed ID: 1273506
    [Abstract] [Full Text] [Related]

  • 5. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F, Akarca US, Ersöz G, Karasu Z, Yüce G, Batur Y.
    Hepatogastroenterology; 2002 Jun 03; 49(47):1195-200. PubMed ID: 12239904
    [Abstract] [Full Text] [Related]

  • 6. [Immunosuppressive therapy of chronic aggressive hepatitis and primary biliary cirrhosis].
    Lampe K, Hüdepohl M, Schopen RD.
    Med Klin; 1972 Apr 14; 67(15):527-34. PubMed ID: 5053009
    [No Abstract] [Full Text] [Related]

  • 7. Effects of medroxyprogesterone on the liver function and drug metabolism of patients with primary biliary cirrhosis and chronic active hepatitis.
    Sotaniemi EA, Hynnynen T, Ahlqvist J, Ahokas JT, Puoskari U, Pelkonen I.
    J Med; 1978 Apr 14; 9(2):117-28. PubMed ID: 276564
    [Abstract] [Full Text] [Related]

  • 8. Immunosuppressive therapy in chronic liver disease.
    Sherlock S.
    Minerva Med; 1978 Aug 18; 69(38):2605-9. PubMed ID: 714260
    [Abstract] [Full Text] [Related]

  • 9. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.
    Corpechot C, Poujol-Robert A, Wendum D, Galotte M, Chrétien Y, Poupon RE, Poupon R.
    Liver Int; 2004 Jun 18; 24(3):187-93. PubMed ID: 15189267
    [Abstract] [Full Text] [Related]

  • 10. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis.
    Ben-Ari Z, Dhillon AP, Sherlock S.
    Hepatology; 1993 Jul 18; 18(1):10-5. PubMed ID: 8100797
    [Abstract] [Full Text] [Related]

  • 11. Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome.
    Twaddell WS, Lefkowitch J, Berk PD.
    Semin Liver Dis; 2008 Feb 18; 28(1):128-34. PubMed ID: 18293283
    [Abstract] [Full Text] [Related]

  • 12. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Michieletti P, Minuk GY, Pappas SC, Scully LJ.
    Hepatology; 1994 May 18; 19(5):1149-56. PubMed ID: 8175136
    [Abstract] [Full Text] [Related]

  • 13. Cryoglobulins in primary biliary cirrhosis: prevalence and modulation by immunosuppressive therapy.
    Taal BG, Schalm SW.
    Z Gastroenterol; 1985 May 18; 23(5):228-34. PubMed ID: 3909671
    [Abstract] [Full Text] [Related]

  • 14. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
    Chazouillères O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R.
    Hepatology; 1998 Aug 18; 28(2):296-301. PubMed ID: 9695990
    [Abstract] [Full Text] [Related]

  • 15. [Histological and clinical studies on the differential diagnosis of the aggressive chronic hepatitis and primary biliary liver cirrhosis].
    Lüders CJ, Kruck P, Henning H, Look D.
    Z Gastroenterol; 1974 Oct 18; 12(6):467-84. PubMed ID: 4428821
    [No Abstract] [Full Text] [Related]

  • 16. [Immunosuppressive treatment of chronic hepatitis].
    Magyar I.
    Dtsch Z Verdau Stoffwechselkr; 1970 Oct 18; 30(1):31-4. PubMed ID: 5501423
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of chronic hepatitis. A comparative study of the effect azathioprine and (+)-cyanidanol-3].
    Aguilar Reina J, de la Santa López J, Cuadras Avellana CM, Kern A.
    Fortschr Med; 1978 Jan 12; 96(2):75-9. PubMed ID: 74352
    [Abstract] [Full Text] [Related]

  • 18. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis.
    Wiesner RH, Ludwig J, Lindor KD, Jorgensen RA, Baldus WP, Homburger HA, Dickson ER.
    N Engl J Med; 1990 May 17; 322(20):1419-24. PubMed ID: 2184355
    [Abstract] [Full Text] [Related]

  • 19. Natural history of pruritus in primary biliary cirrhosis.
    Talwalkar JA, Souto E, Jorgensen RA, Lindor KD.
    Clin Gastroenterol Hepatol; 2003 Jul 17; 1(4):297-302. PubMed ID: 15017671
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis.
    Van de Water J, Gerson LB, Ferrell LD, Lake JR, Coppel RL, Batts KP, Wiesner RH, Gershwin ME.
    Hepatology; 1996 Nov 17; 24(5):1079-84. PubMed ID: 8903379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.